Kestra Advisory Services’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$519K Sell
7,340
-140
-2% -$7.56K ﹤0.01% 2319
2026
Q1
$391K Sell
7,480
-476
-6% -$28.6K ﹤0.01% 2419
2025
Q4
$468K Buy
7,956
+257
+3% +$15.6K ﹤0.01% 2203
2025
Q3
$428K Sell
7,699
-570
-7% -$30.5K ﹤0.01% 2165
2025
Q2
$425K Sell
8,269
-15,156
-65% -$762K ﹤0.01% 2083
2025
Q1
$1.37M Sell
23,425
-8,165
-26% -$553K 0.01% 1193
2024
Q4
$2.28M Buy
31,590
+889
+3% +$65.3K 0.01% 935
2024
Q3
$2.45M Sell
30,701
-1,335
-4% -$100K 0.01% 857
2024
Q2
$2.3M Sell
32,036
-8,693
-21% -$640K 0.01% 896
2024
Q1
$2.87M Buy
40,729
+9,089
+29% +$650K 0.02% 727
2023
Q4
$2.44M Sell
31,640
-1,126
-3% -$74.2K 0.02% 708
2023
Q3
$2.23M Buy
32,766
+27,647
+540% +$2.18M 0.02% 644
2023
Q2
$418K Sell
5,119
-872
-15% -$70.1K ﹤0.01% 1417
2023
Q1
$444K Sell
5,991
-3,750
-38% -$289K ﹤0.01% 1340
2022
Q4
$807K Sell
9,741
-28,703
-75% -$2.28M 0.01% 1157
2022
Q3
$2.73M Buy
38,444
+28,856
+301% +$2.49M 0.03% 561
2022
Q2
$831K Buy
9,588
+896
+10% +$84K 0.01% 1066
2022
Q1
$941K Buy
8,692
+228
+3% +$23.5K 0.01% 995
2021
Q4
$1.09M Buy
8,464
+76
+0.9% +$9.32K 0.01% 940
2021
Q3
$1.02M Buy
8,388
+136
+2% +$16.6K 0.01% 1009
2021
Q2
$929K Sell
8,252
-884
-10% -$93K 0.01% 983
2021
Q1
$872K Sell
9,136
-38,104
-81% -$3.48M 0.01% 938
2020
Q4
$3.74M Buy
47,240
+47,160
+58,950% +$3.42M 0.04% 414
2020
Q3
$429K Buy
+80
New +$5.2K 0.01% 952

Other funds holding TECH

Kestra Advisory Services's TECH Position: Q2 2026 in Review

Kestra Advisory Services reduced its Bio-Techne (TECH) stake by 1.9% in Q2 2026, selling an estimated $7.56K and leaving 7,340 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

Kestra Advisory Services first reported a position in TECH in Q3 2020 and has held it in 24 quarters since. The position peaked at $3.74M in Q4 2020. 149 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Kestra Advisory Services held 7,340 shares of Bio-Techne worth $519K as of Q2 2026.
  • Kestra Advisory Services sold 140 Bio-Techne shares in Q2 2026, an estimated $7.56K.
  • Bio-Techne made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2319 holding.
  • Kestra Advisory Services first reported a position in Bio-Techne in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's Bio-Techne position peaked at $3.74M in Q4 2020.
  • 149 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.